SE8603284L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8603284L
SE8603284L SE8603284A SE8603284A SE8603284L SE 8603284 L SE8603284 L SE 8603284L SE 8603284 A SE8603284 A SE 8603284A SE 8603284 A SE8603284 A SE 8603284A SE 8603284 L SE8603284 L SE 8603284L
Authority
SE
Sweden
Prior art keywords
antiviral
antitumor
group
adjuvant
compound
Prior art date
Application number
SE8603284A
Other languages
English (en)
Other versions
SE501592C2 (sv
SE8603284D0 (sv
Inventor
G Sauer
E Amtmann
K W Hummel
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of SE8603284D0 publication Critical patent/SE8603284D0/sv
Publication of SE8603284L publication Critical patent/SE8603284L/sv
Publication of SE501592C2 publication Critical patent/SE501592C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8603284A 1985-08-02 1986-08-01 Antivirus- och antitumörkomposition innefattande ett antivirus- och antitumörxantat och en jonisk adjuvantförening SE501592C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3527871 1985-08-02
DE3620939 1986-06-23

Publications (3)

Publication Number Publication Date
SE8603284D0 SE8603284D0 (sv) 1986-08-01
SE8603284L true SE8603284L (sv) 1987-02-03
SE501592C2 SE501592C2 (sv) 1995-03-20

Family

ID=25834701

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603284A SE501592C2 (sv) 1985-08-02 1986-08-01 Antivirus- och antitumörkomposition innefattande ett antivirus- och antitumörxantat och en jonisk adjuvantförening

Country Status (14)

Country Link
US (1) US4851435A (sv)
JP (1) JPH0618786B2 (sv)
AU (1) AU585380B2 (sv)
BE (1) BE905195A (sv)
CA (1) CA1295944C (sv)
CH (1) CH673224A5 (sv)
DK (1) DK369186A (sv)
FR (1) FR2591483B1 (sv)
GB (1) GB2178957B (sv)
GR (1) GR862030B (sv)
IT (1) IT1213453B (sv)
LU (1) LU86533A1 (sv)
NL (1) NL8601895A (sv)
SE (1) SE501592C2 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT392906B (de) * 1987-10-08 1991-07-10 Hoffmann La Roche Pharmazeutische praeparate zur oralen verabreichung
CA2010511A1 (en) * 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
AU4159596A (en) * 1994-11-14 1996-06-06 Ct-Holding Sa Antiviral and antitumor pharmaceutical compositions
DE10117728A1 (de) * 2001-04-09 2002-10-17 Biosphings Ag Pharmazeutische Formulierungen für Xanthogenate
DE10156617A1 (de) * 2001-11-17 2003-05-28 Biosphings Ag Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ATE521355T1 (de) * 2004-05-19 2011-09-15 Los Angeles Biomed Res Inst Verwendung eines detergens zur nicht- chirurgischen entfernung von fett
DE102006014390A1 (de) 2006-03-29 2007-10-04 Biosphings Ag Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung
CA2691807A1 (en) * 2007-07-03 2009-01-08 Lumavita Ag Stereoisomers of tricyclodecan-9-yl-xanthogenate
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CA2827643C (en) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020183A (en) * 1974-12-03 1977-04-26 Ortho Pharmaceutical Corporation Nonionic surface active anti-herpes simplex viral agents
CA1174978A (en) * 1980-11-26 1984-09-25 Arthur Scherm Xanthates
KR870001238B1 (ko) * 1980-11-26 1987-06-26 메르츠+캄패니 게엠베하 앤드 캄패니 크산틴산염의 제조방법
DK315482A (da) * 1981-07-20 1983-01-21 Kimberly Clark Co Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden

Also Published As

Publication number Publication date
AU6064886A (en) 1987-02-05
GR862030B (en) 1986-12-24
GB8618820D0 (en) 1986-09-10
SE501592C2 (sv) 1995-03-20
BE905195A (fr) 1987-01-29
DK369186D0 (da) 1986-08-01
SE8603284D0 (sv) 1986-08-01
GB2178957B (en) 1989-12-28
US4851435A (en) 1989-07-25
IT1213453B (it) 1989-12-20
FR2591483B1 (fr) 1990-08-10
CA1295944C (en) 1992-02-18
CH673224A5 (sv) 1990-02-28
NL8601895A (nl) 1987-03-02
DK369186A (da) 1987-02-03
IT8621192A0 (it) 1986-07-21
LU86533A1 (fr) 1988-02-02
JPH0618786B2 (ja) 1994-03-16
GB2178957A (en) 1987-02-25
AU585380B2 (en) 1989-06-15
JPS6259223A (ja) 1987-03-14
FR2591483A1 (fr) 1987-06-19

Similar Documents

Publication Publication Date Title
SE8603284D0 (sv) Pharmaceutical composition
EA199700267A1 (ru) Применение фумагиллола и его производных для приготовления антиинфекционных интестинальных препаратов и фармацевтическая композиция на их основе
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
DE3381396D1 (de) Formulierung nicht irritierender ophthalmischer waesseriger zusammensetzungen fuer okular-therapeutische mittel.
FR983618A (fr) Perfectionnements à la préparation de tri-esters d'acide di-thiophosphorique
SE8301395D0 (sv) Kelatiserande foreningar med funktionella grupper vilka tillater kovalent koppling till bio-organiska molekyler
CA2081356A1 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n- acetyl neuraminic acid and their use as antiviral agents
BR9809910A (pt) Peptìdeos lh-rh análogos, seus usos e composições farmacêuticas contendo-os
ES2061740T3 (es) Estabilizacion de masas de organopolisiloxanos reticulables para formar elastomeros con separacion de alcoholes.
PT90478A (pt) Processo para a preparacao de derivados da purina e de composicoes farmaceuticas que os contem
GB1389429A (en) Gypsum boards
ES2052166T3 (es) Derivados de 24-homo-vitamina-d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.
SE8900828D0 (sv) Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma
FR2359144A1 (fr) Sels de l'acide clavulanique utilisable comme medicaments
DE3485638D1 (de) Zubereitung von nitroestern fuer die koronartherapie.
SE8303696D0 (sv) Farmakologiska kompositioner
KR860008770A (ko) 화 장 품
KR880007059A (ko) 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액 제제
DK403187A (da) Praeparat til transdermal indgift
KR880007080A (ko) 제약학적 생성물
KR890005088A (ko) 4- 아미노피리딘 유도체 및 그의 산 부가염
PT83624B (pt) Processo para a preparacao de composicoes farmaceuticas contendo analogos da prostaglandina
PT82815B (pt) Processo de preparacao de derivados da imidazolidina, dos seus sais farmaceuticamente aceitaveis e das composicoes farmaceuticas que os contem
FI863311A (fi) Farmaceutiska kompositioner innehaollande acylerade fosfolipider.